Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|May 9, 2016
Production and in vivo imaging of (203)Pb as a surrogate isotope for in vivo (212)Pb internal absorbed dose studiesDomokos Máthé, Krisztián Szigeti, Nikolett Hegedűs, et al.Cancer Biotherapy & Radiopharmaceuticals|June 17, 2016
Radiolabeling of Extracellular Vesicles with (99m)Tc for Quantitative In Vivo Imaging StudiesZoltán Varga, István Gyurkó, Krisztina Pálóczi, et al.Contrast Media & Molecular Imaging|December 6, 2018
Multimodal PET/MRI Imaging Results Enable Monitoring the Side Effects of Radiation TherapyNoémi Kovács, Krisztián Szigeti, Nikolett Hegedűs, et al.Journal of Psychopharmacology (Oxford, England)|January 15, 2015
Scopolamine provocation-based pharmacological MRI model for testing procognitive agentsNikolett Hegedűs, Judit Laszy, István Gyertyán, et al.Plos One|May 17, 2014
Ghrelin modulates the fMRI BOLD response of homeostatic and hedonic brain centers regulating energy balance in the ratMiklós Sárvári, Pál Kocsis, Levente Deli, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 20, 2014
Vascular action as the primary mechanism of cognitive effects of cholinergic, CNS-acting drugs, a rat phMRI BOLD studyPál Kocsis, István Gyertyán, János Éles, et al.EJNMMI Research|July 27, 2019
Radiomic detection of microscopic tumorous lesions in small animal liver SPECT imagingDániel S Veres, Domokos Máthé, Nikolett Hegedűs, et al.Nanomaterials (Basel, Switzerland)|September 4, 2020
Fluorescent, Prussian Blue-Based Biocompatible Nanoparticle System for Multimodal Imaging ContrastLászló Forgách, Nikolett Hegedűs, Ildikó Horváth, et al.Plos One|July 20, 2022
Synthesis and preclinical application of a Prussian blue-based dual fluorescent and magnetic contrast agent (CA)Nikolett Hegedűs, László Forgách, Bálint Kiss, et al.Plos One|November 30, 2023
Correction: Synthesis and preclinical application of a Prussian blue-based dual fluorescent and magnetic contrast agent (CA)Nikolett Hegedűs, László Forgách, Bálint Kiss, et al.Pageof 2